Harrow, Inc.
HROW
#5640
Rank
C$2.04 B
Marketcap
C$54.57
Share price
-4.84%
Change (1 day)
2.27%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): C$15.98 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are C$0.26 Billion. In 2025 the company made an earning of C$31.64 Million, an increase over its 2024 earnings that were of C$7.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$15.98 M-49.5%
2025 C$31.64 M317.34%
2024 C$7.58 M-329.09%
2023 -C$3.32 Million-224.34%
2022 C$2.66 M3.01%
2021 C$2.58 M149.06%
2020 C$1.03 M434.29%
2019 C$0.19 M-102.68%
2018 -C$7.24 Million-57.11%
2017 -C$16.88 Million-21.93%
2016 -C$21.62 Million5.11%
2015 -C$20.57 Million46.16%
2014 -C$14.07 Million32.68%
2013 -C$10.61 Million42.63%
2012 -C$7.44 Million
2010 -C$3.44 Million-45.76%
2009 -C$6.34 Million21.83%
2008 -C$5.2 Million-491.97%
2007 C$1.32 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.32 Billion-2,013.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.19 Million-251.76%๐Ÿ‡บ๐Ÿ‡ธ USA